| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.031 | 0.5 |